The anthracyclines are antibiotics effective in the treatment of many
malignancies. However, their usefulness is limited by the development
of potentially acute or chronic cardiotoxicity. No definitive guidelin
es exist for monitoring cardiac function during and after anthracyclin
es although methods have been suggested. Electrocardiograms and echoca
rdiograms are routinely utilized for noninvasive assessment of myocard
ial function. The aim of the study was to assess the effects of doxoru
bicin on ventricular repolarization time indexes, as they have been sh
own to be effective in the identification of electrical myocardial ins
tability and hence in the identification of the risk for either arrhyt
hmia or heart failure. Electrocardiographic parameters were compared i
n 27 cancer patients before and after chemotherapy including doxorubic
in. The data of the present study show that after only a short period
of treatment with doxorubicin there is a significant increase in ventr
icular recovery time indexes (QTc dispersion and 'Adjusted' QTc disper
sion). The relation between the electrophysiological response to doxor
ubicin and the potential cardiotoxic effect of this drug remains to be
established through prospective studies.